Tamoxifen (TAM) for the prevention of breast cancer: Importance of specific aspects of health-related quality of life (HRQL) to global health status in the ANZ BCTG substudy of IBIS-1 (ANZ 92P1)

التفاصيل البيبلوغرافية
العنوان: Tamoxifen (TAM) for the prevention of breast cancer: Importance of specific aspects of health-related quality of life (HRQL) to global health status in the ANZ BCTG substudy of IBIS-1 (ANZ 92P1)
المؤلفون: Peter Grimison, Paul Craft, John F. Forbes, R. M. Thornton, C. Furnival, Jack Cuzick, D. F. Lindsay, A. S. Coates, Raymond Snyder, R. J. Simes
المصدر: Journal of Clinical Oncology. 26:1516-1516
بيانات النشر: American Society of Clinical Oncology (ASCO), 2008.
سنة النشر: 2008
مصطلحات موضوعية: Ibis, Health related quality of life, Cancer Research, medicine.medical_specialty, biology, business.industry, Incidence (epidemiology), education, medicine.disease, biology.organism_classification, Placebo, Breast cancer, Increased risk, Oncology, Internal medicine, medicine, Physical therapy, Global health, skin and connective tissue diseases, business, Tamoxifen, medicine.drug
الوصف: 1516 Background: The International Breast Cancer Intervention Study (IBIS-1) found that 5 years of TAM compared to placebo reduced the incidence of invasive breast cancer in women at increased risk...
تدمد: 1527-7755
0732-183X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7e8c60a3e956764556a5fe653f0171f1
https://doi.org/10.1200/jco.2008.26.15_suppl.1516
رقم الأكسشن: edsair.doi...........7e8c60a3e956764556a5fe653f0171f1
قاعدة البيانات: OpenAIRE